Definition:
A nucleoside reverse transcriptase inhibitor (NRTI) first approved by FDA in 1992 and used in combination with other antiretroviral agents for the treatment of HIV infection in patients 13 years of age and older.
A nucleoside reverse transcriptase inhibitor (NRTI) first approved by FDA in 1992 and used in combination with other antiretroviral agents for the treatment of HIV infection in patients 13 years of age and older.
Also Known As:
- DDC
- Zalcitabine
